Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.83 |
| ▸ | CA9 | Q16790 | 1/20 | 0.83 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.40 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.40 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6336925 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6334899 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL14900343 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6341515 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL11539210 | 1.00 | CA1 (0.83) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL876932 | 0.97 | CA1 (0.88) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL2852822 | 0.95 | CA1 (0.84) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6346930 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL11552580 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL7053729 | 0.94 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11787918-B2 | Biobased compositions | Evoco Limited (CA) | 2023-10-17 | — | — | US | claimed |
| WO-2022174333-A1 | BIOBASED COMPOSITIONS | Evoco Limited (CA) | 2022-08-25 | — | — | WO | claimed |
| US-20220259402-A1 | BIOBASED COMPOSITIONS | Evoco Limited (CA) | 2022-08-18 | — | — | US | claimed |
| CN-113769172-A | Multi-orientation biological artificial blood vessel and preparation method thereof | 扬州大学 | 2021-12-10 | — | — | CN | claimed |
| CN-107121902-B | Toner compositions and methods | 施乐公司 | 2020-11-27 | — | — | CN | claimed |
| CN-117547612-A | Preparation method and application of bladder cancer drug release system based on fully degradable shape memory material | 复旦大学附属中山医院 | 2024-02-13 | — | — | CN | disclosed |
| US-11787918-B2 | Biobased compositions | Evoco Limited (CA) | 2023-10-17 | — | — | US | disclosed |
| CN-115969593-A | Drug-loaded 3D printing degradable venous external stent and construction method thereof | 中国人民解放军空军军医大学 | 2023-04-18 | — | — | CN | disclosed |
| WO-2022174333-A1 | BIOBASED COMPOSITIONS | Evoco Limited (CA) | 2022-08-25 | — | — | WO | disclosed |
| US-20220259402-A1 | BIOBASED COMPOSITIONS | Evoco Limited (CA) | 2022-08-18 | — | — | US | disclosed |
| CN-108137760-B | (meth) acrylic copolymer and method for producing same, polymer solution, polymer-containing composition, and antifouling paint composition | 三菱化学株式会社 | 2022-03-15 | — | — | CN | disclosed |
| CN-114028602-A | Preparation method of high-elasticity antibacterial nanofiber film for wound healing | 苏州汇涵医用科技发展有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113769172-A | Multi-orientation biological artificial blood vessel and preparation method thereof | 扬州大学 | 2021-12-10 | — | — | CN | disclosed |
| CN-112266549-A | Graphene-reinforced hard PVC heat-conducting composite material and preparation method thereof | 新奥石墨烯技术有限公司 | 2021-01-26 | — | — | CN | disclosed |
| CN-107121902-B | Toner compositions and methods | 施乐公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-107418099-B | Very low-precipitation polyvinyl chloride composition and preparation method thereof | 揭阳市圣路保鞋业有限公司 | 2019-12-13 | — | — | CN | disclosed |
| US-6846862-B2 | Binder system and method for particulate material cross-reference to related application | APEX ADVANCED TECHNOLOGIES, LLC (US) | 2005-01-25 | — | — | US | disclosed |
| WO-2002000569-A2 | BINDER SYSTEM AND METHOD FOR FORMING SINTERED PARTS BY POWDER INJECTION MOLDING | APEX ADVANCED TECHNOLOGIES, LLC (US) | 2002-01-03 | — | — | WO | disclosed |
| US-5446109-A | Melt reacting while heating in presence of a phenolic compound | TEIJIN LIMITED (JP) | 1995-08-29 | — | — | US | disclosed |
| US-3967962-A | ELECTROGRAPHY | XEROX CORPORATION (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220259402-A1 | BIOBASED COMPOSITIONS | SORD, SCD, ACMSD | CA1 1115/4885CA9 755/4885ALDH1A1 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.